TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.

Other languages Tonghua Dongbao Pharmaceutical Co., Ltd.

Equities

600867

CNE000000H87

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
10.09 ^CNY	-0.88%		-2.13%	-6.83%

Apr. 29	Dongbao Pharmaceutical's Profit, Operating Income Slip in Q1 2024	MT
Apr. 26	Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dongbao Pharmaceutical's Profit, Operating Income Slip in Q1 2024	Apr. 29
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26
Dongbao Pharma's 2023 Profit Drops 26%	Mar. 29
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 29
Dongbao Pharma Unit's Gout Drug Clinical Study Achieves Primary Endpoint	Jan. 17
Dongbao Pharmaceutical's Unit Gets Nod to Trial Diabetes Drug	Dec. 27
Dongbao Pharmaceutical Unit Gets Nod to Trial Diabetes Drug	Dec. 12
Tonghua Dongbao Pharma Unit Enrolls First Subject for Clinical Trial of Diabetes Drug	Dec. 06
Tonghua Dongbao Pharma Registers Diabetes Drug	Dec. 05
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30
Tonghua Dongbao Pharmaceutical's Insulin Injection Shows Positive Results in German Trial	23-10-24
Adocia : en nette hausse après des résultats positifs contre le diabète	23-10-23
Adocia Announces its Partner Tonghua Dongbao Releases Positive Results on the Three Clinical Studies Conducted on BioChaperone Combo THDB0207 Formulation Containing Insulin Glargine and Insulin Lispro from Tonghua Dongbao	23-10-23
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Announces an Exclusive Licensing Agreement with Tonghua Dongbao Pharmaceutical Co., Ltd. to Commercialize Three Insulin Biosimilars - Insulin Aspart, Insulin Lispro, and Insulin Glargine in the U.S	23-09-21
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-21
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26
Tonghua Dongbao Pharmaceutical Enrolls First Subject for Phase II Trial of Gout Drug; Shares Rose 4%	23-02-08
Tonghua Dongbao Pharma’s Net Profit Jumps 21% Despite Revenue Drop	23-02-07
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-06
Tonghua Dongbao Pharma Wins Nod to Trial Drug Against Uric Acid, Gout	22-12-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Tonghua Dongbao Pharmaceutical Co., Ltd.

Equities

600867

CNE000000H87

Other languages

Filters